Pahl Pharmaceutical Professionals, LLC is a clinical drug trial center specializing in Phase I, II, and III psychiatric and neurological clinical drug trials in children, adults, and geriatric populations.
We at Pahl Pharmaceutical Professionals pride ourselves on our courteous staff, our hospitality to our patients, great relations with our Sponsors and CROs and our attention to detail. Our study coordinators are very well trained and have a minimum of five years experience with clinical drug trials. While we are a new company, our Principle Investigator, Dr. Jörg J. Pahl, M.D., F.C.P. (S.A.) has completed over 200 clinical drug studies in Oklahoma. These studies have covered a wide spectrum of psychiatric and neurological disorders including Addiction (Opioid and Methamphetamine), Alzheimer's Disease, and Mood Disorders (Depression, Generalized Anxiety Disorder, etc.), just to name a few. Current studies include trials in opioid and methamphetamine addiction as well as Generalized Anxiety Disorder (GAD) and Alzheimer’s Disease. The center has a special interest in utilizing brain imaging techniques such as MRI and PET as diagnostic tests. For a complete list of trials conducted by Dr. Pahl please refer to the “About Us” tab where you will not only find the list of completed studies but lists specific to each disorder as well.
“We make a living by what we get. We make a life by what we give.”